Background: Gestational diabetes mellitus is a metabolic disorder defi ned as glucose intolerance with the onset or fi rst recognition during pregnancy. Gestational diabetes mellitus is associated with higher incidence of maternal diabetes mellitus later in life. It poses a risk to the pregnant woman and to the fetus. Hence, it is imperative for an early detection and management of the disease to ensure better maternal and foetal outcomes. Objective: To assess the prevalence of gestational diabetes mellitus and to analyze the maternal and perinatal outcomes of gestational diabetes mellitus patients who delivered in the hospital during the study period. Methods: A hospital based descriptive observational study was conducted at Kathmandu Medical College Teaching Hospital for a period of one year from 1 st January 2013 to 31 st December 2013. All the cases of gestational diabetes mellitus were included in the study. Patients were followed from the time of admission to the time of discharge after delivery. Pertinent information obtained were demography, gestational age at diagnosis and delivery, pregnancy complications, intervention and perinatal morbidity and mortality. Results: Out of 2845 deliveries, 45 patients were diagnosed as gestational diabetes mellitus and admitted during the period of study. The prevalence of gestational diabetes mellitus was 1.58% in this hospital. The most common maternal and neonatal complications were gestational hypertension (20%), hypoglycemia (8.89%) and macrosomia (8.89%) respectively. Conclusion: This study is important in providing information about the maternal and neonatal outcomes of gestational diabetes. By proper monitoring and good glycaemic control during the antenatal period, the adverse maternal and neonatal complications of gestational diabetes mellitus can also be reduced.
like macrosomia, polyhydramnios, preterm labour, respiratory distress, unexplained intrauterine foetal death, traumatic delivery and neonatal complications like hypoglycaemia, jaundice, polycythaemia, hypocalcaemia and hypomagnesaemia 3 . According to a large-scale multinational epidemiologic study, the risk of adverse maternal and perinatal outcomes constantly increased as a function of maternal glycaemia at 24-28 weeks of gestation. No threshold for the majority of these complications was found, but prevention and early detection of GDM is a growing health concern 4 . In majority of women with gestational diabetes, glucose tolerance returns to normal but one-third to two-thirds of women will have glucose intolerance in subsequent pregnancies 5, 6 . Recently, the effect of screening and clinical management of GDM on antenatal, neonatal and perinatal outcome has been proved to be benefi cial 7 .
Since very little data is available regarding gestational diabetes in our context, this study was done to 
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This hospital based observational and descriptive study was carried out in Kathmandu Medical College Teaching Hospital (KMCTH), in the Department of Obstetrics and Gynaecology over a period of one year from 1 st January 2013 to 31 st December 2013. All women diagnosed with GDM and delivered at KMCTH were included in the study. Patients were followed from the time of admission to the time of discharge and their outcomes noted.
Data on maternal age, gestational age at diagnosis, gestational age at delivery, mode of delivery and diabetes management were collected, as well as data on birth weight, Apgar scores at one minute and fi ve minute, neonatal complications like hypoglycaemia, hyperbilirubinaemia, respiratory distress syndrome, macrosomic baby and intensive care unit (NICU) admission were also collected and analysed.
At this institution, in all the pregnant ladies irrespective of high risk for GDM, the universal screening test done is the 50-g oral glucose challenge test (GCT), administered between 24 and 28 weeks of pregnancy. Also those women who had their antenatal check-up done outside and those who were missed for screening during 24-28 weeks were advised to do GCT during antenatal checkup in this institution. Women with an abnormal GCT result ie, blood glucose levels ≥140 mg/dL after two hours of oral glucose further received a 100-g, three hour oral glucose tolerance test (OGTT). If two or more values were abnormal, the patient was admitted as GDM and fi ve-profi le blood sugar was carried out which included the following samples: Fasting, pre-lunch, two hour post lunch, pre-dinner and two hour post dinner. Patients were treated with Metformin or insulin or combination of both the drugs depending upon the consultants' discretion and their fi ve sugar profi le report during antenatal period. The usual starting dose of Metformin was 500 mg to 1500 mg daily in divided doses and insulin dose was individualized and adjusted according to need of the patient. The goal of glycaemic control was to achieve pre-prandial blood sugar of 95-105 mg/dL and post-prandial blood sugar of ≤140 mg/ dL 8 . Patients with controlled GDM were allowed to go beyond the 38 th completed weeks. None, however, were allowed to go beyond 40 weeks of pregnancy. Induction of labour was carried out at term pregnancies and those associated with gestational hypertension. Elective caesarean section was done for diabetics with foetal macrosomia and emergency caesarean section for obstetrical indications.
Euglycaemia was achieved during labour and prior to elective caesarean section. Blood glucose concentration was measured every two hours in latent phase and every hourly in active phase of labour; blood glucose concentration higher than 120-140 mg/dL was treated with an infusion of intravenous short acting regular insulin and dose adjusted to maintain the blood glucose concentration between 70-110 mg/dL 9 .
After delivery, neonates were admitted to the newborn nursery unless they required intensive care. Glucose monitoring was performed for all neonates born to patients with GDM. The monitoring was done with a glucometer and done at 0, 1, 2, 3, 6, 12, 24, 36 and 48 hours of life 10 .
Since there is increased risk of development of type 2 DM in patients of GDM 11 , all the GDM patients after their delivery and upon their discharge, were advised to perform a 75 g GTT at 6-8 weeks postpartum. Other neonatal complications like hypocalcaemia, respiratory distress syndrome (RDS) including transient tachypnoea were considered and stay of ≥24 hours in neonatal intensive care unit (NICU) were also obtained from the medical records. Apgar score taken at one minute and fi ve minutes were obtained from the birth chart.
Data was analysed using Microsoft Excel version 7 on personal computer and subjected to descriptive analysis.
RESULTS
During the study period, a total of 2845 deliveries were conducted in the Department of Obstetrics and Gynaecology at KMCTH, out of which 45 (1.58%) patients were diagnosed as GDM. The overall mean age of GDM patients in this study was 30.02±3.513 years; likewise, the mean parity was 1.71±0.757 ( (Table 2) . Nine patients (20%) developed gestational hypertension (Table 3) . On the other hand, three (6.6%) neonates were admitted to NICU for sepsis screening because their mother had prelabour rupture of membrane. Three neonates had jaundice but did not require phototherapy. Four neonates (8.89%) had hypoglycaemia and two (4.44%) had respiratory distress syndrome (Table 4) . 
DISCUSSION
GDM has been recognized as a clinical entity for the past 50 years 12 and the GDM prevalence has been reported variably from 1.4 to 14% worldwide, differently among racial and ethnic groups. Prevalence is higher in Blacks, Latino, Native Americans and Asian women than White women 13 . In this study, the prevalence of GDM was 1.58% which is similar to the studies done around the world 9 but slightly higher than the study done by Paban K et al 14 , at the Patan Hospital where the prevalence was only 0.2%. Nilofer 15 in Davengere, Karnataka, performed a similar study and found a prevalence rate of 6% and Wahi et al 16 from Jammu found a prevalence rate of 6.94%. Our study revealed that the most common complications seen in GDM mother was gestational hypertension (20%) followed by prelabour rupture of membrane (PROM; 6.67%) and preterm labour (4.4%). Similar complications were seen in the study done by Kalra et al 17 , where complication seen in GDM patients were gestational hypertension (36.4%) and PROM (18.1%). Many studies have found high caesarean delivery rates in GDM patients despite good maternal glucose control during pregnancy 11, 18, 19 . Malak 20 from
Saudi Arabia found LSCS rate of 21.6% and spontaneous vertex deliveries of 74.6% in the GDM patients however, LSCS rate in this study was 42.2% and normal delivery 44.4%.The main indications for LSCS in this study were maternal gestational hypertension, macrosomia, nonreassuring foetal heart tracing, failure to progress and previous history of caesarean section. 23 , also found an incidence of 6.5% of macrosomia in the GDM patients which is in concordance with this study where the incidence is 8.8%. Many complications of pregnancy that are commonly associated with GDM such as polyhydramnios, oligohydramnios, congenital anomalies, shoulder dystocia and still births which were not found in this study. The reason might be due to universal GDM screenings done during antenatal period, early recognition of macrosomia and planned elective .
Randomized clinical trials confi rmed that treated GDM patients would have reduced risks of having neonatal birth complications as well as blood pressure disorders in the mothers 25 . Some studies concluded that even very mild alterations in glucose tolerance can result in abnormal foetal growth which can be prevented by simple but aggressive control of blood sugars in order to ameliorate many complications for the mother and the baby 26 .
CONCLUSION
The management of GDM has altered markedly in recent years. This study is important in providing information about the maternal and neonatal outcomes of gestational diabetes. By proper monitoring and good glycaemic control during the antenatal period, the adverse maternal and neonatal complications of gestational diabetes mellitus can be reduced. Hence, more efforts to assure early recognition and strict sugar control during pregnancy are recommended.
